好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Neurodevelopmental Disorders

Friday 04/27/12
01:00 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
PM Half-Day Course
Imad T. Jarjour, MD, FAAN
Cerebrovascular Disease and Interventional Neurology
Upon Completion: Participants should become familiar with early diagnosis of cerebral palsy, autism, epilepsy, and other neurodevelopmental disabilities, and be familiar with new advances and clinical guidelines for diagnostic testing and therpaeutic interventions
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Subspecialty in Focus
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic, Interactive, Audience Participation

Program Evaluations

Event Timeline
01:00 PM - 01:10 PM Welcome and Introduction
Imad T. Jarjour, MD, FAAN
01:10 PM - 01:50 PM Cerebral Palsy: New Advances in Understanding and Management
Michael I. Shevell, MD, FAAN
01:50 PM - 01:55 PM Questions and Answers
01:55 PM - 02:35 PM Extreme Prematurity: Update on Neurodevelopmental Outcomes
Imad T. Jarjour, MD, FAAN
02:35 PM - 02:40 PM Questions and Answers
02:40 PM - 02:55 PM Break
02:55 PM - 03:35 PM Brain Malformations: Bridging Neuroscience, Genetics, and the Clinic
Gary D. Clark, MD
03:35 PM - 03:40 PM Questions and Answers
03:40 PM - 04:20 PM Neuropsychological Functioning in Children with Seizures
David W. Dunn, MD
04:20 PM - 05:00 PM Questions and Answers
Gary D. Clark, MD, David W. Dunn, MD, Imad T. Jarjour, MD, FAAN, Michael I. Shevell, MD, FAAN
Faculty Disclosures
Imad T. Jarjour, MD, FAAN No disclosure on file
David W. Dunn, MD Dr. Dunn has nothing to disclose.
Michael I. Shevell, MD, FAAN Dr. Shevell has nothing to disclose.
Gary D. Clark, MD The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.